Article
A high throughput bispecific antibody discovery pipeline
7 Apr 2023
Abstract excerpt
Bispecific antibodies (BsAbs) represent an emerging class of immunotherapy, but inefficiency in the current discovery has limited their broad clinical availability. Here we report a high throughput, agnostic, single-cell-based functional screening pipeline, comprising molecular and cell engineering for efficient generation of BsAb library cells, followed by functional interrogation at the single-cell level to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
